Detalhe da pesquisa
1.
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure.
Blood
; 135(19): 1650-1660, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076701
2.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Eur J Haematol
; 108(5): 437-445, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122325
3.
High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy.
Blood
; 134(7): 636-640, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648294
4.
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.
Blood
; 133(15): 1652-1663, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728140
5.
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.
Blood
; 133(17): 1876-1887, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782611
6.
Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy.
Blood
; 131(1): 121-130, 2018 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29038338
7.
Potentials, challenges and future of chimeric antigen receptor T-cell therapy in non-Hodgkin lymphomas.
Acta Oncol
; 59(7): 766-774, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32189546
8.
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.
Blood
; 130(21): 2295-2306, 2017 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28924019
9.
Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy.
Br J Haematol
; 183(3): 364-374, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30407609
10.
Innovations en immunothérapie anticancéreuse: thérapie par lymphocytes T porteurs de récepteurs antigéniques chimériques (cellules CAR-T).
CMAJ
; 193(42): E1639-E1642, 2021 10 25.
Artigo
em Francês
| MEDLINE | ID: mdl-34697102
11.
Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T).
CMAJ
; 193(33): E1300-E1302, 2021 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34426446
12.
Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndrome.
Br J Haematol
; 190(3): e150-e154, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32584416
13.
Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study.
Br J Haematol
; 191(1): e14-e19, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688454
14.
Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British Columbia.
Oncologist
; 19(3): 283-90, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24569946
15.
Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22.
Mol Ther Oncol
; 32(1): 200775, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38596311
16.
A systematic review and meta-analysis of CD22 CAR T-cells alone or in combination with CD19 CAR T-cells.
Front Immunol
; 14: 1178403, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37180149
17.
Identifying effect modifiers of CAR-T cell therapeutic efficacy: a systematic review and individual patient data meta-analysis protocol.
Syst Rev
; 12(1): 9, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653879
18.
Hematopoietic Cell Transplantation Trends and Outcomes in Canada: A Registry-Based Cohort Study.
Curr Oncol
; 30(11): 9953-9967, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999143
19.
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies.
Front Immunol
; 13: 1074740, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601119
20.
Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis.
Syst Rev
; 10(1): 35, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33478595